drugset / Trial / NCT01227863
Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B - Union Chemicals), comparing it to the topical medication Maxitrol ® (dexamethasone, neomycin and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the end of treatment, among the products studied.
Timeline
- Start
- 2011-02
- Primary completion
- 2011-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dexamethasone | Small molecule | 0.1 % | — |
| Background | Dexamethasone | Small molecule | 0.1 % | Topical |
| Background | Neomycin | Unknown | 0.35 % | — |
| Background | Neomycin | Unknown | 0.35 % | Topical |
| Background | Polymyxin B | Peptide | 0.1 % | — |
| Background | Polymyxin B | Peptide | 0.1 % | Topical |